Home
Site Map
Contact us
Québec Portal
Media Relations
Employment
Français

INESSS Express
Restricted access

Abonnement à l'INESSS Express
Abonnement aux veilles de l'INESSS
Cancerology Algorithms
Consult publications
Emplois
Drug products
Optimal use guides
Knowledge transfert tools
Medical protocols and related prescriptions

COVID-19
About Us
Methods
- Démarche
Topics
Publications
Projects
- On-going projects
- Quality Indicators: Managing Chronic Diseases
Education and Knowledge transfer

Nous joindre
Portail Québec
Salle de presse
Emplois

INESSS Express
Restricted access

Drug products undergoing evaluation and evaluated

Notices to the Minister
Manufacturer Pricing Notices
Autres publications

Evaluation process and criteria

Accelerated Evaluation of First Multisource Drugs
Evaluation of Drugs for Listing Purposes
Drug products waiting for Notice of Compliance
Exigences de recevabilité pour les thérapies agnostiques en oncologie
Exceptional Medications
Evaluation of Biosimilars
Evaluation of Requests for Exemption from the Lowest Price Method (LPM)
Procedures for scheduling assessment requests

A Meeting Place for Patients, Caregivers and Patient Associations

Why and How to Contribute
Consultation Process and Methods
Faire un commentaire sur un médicament
Publications

Rendez-vous des cliniciens

Pourquoi et comment contribuer aux travaux
Processus et méthodes de consultation
Faire un commentaire sur un médicament
Participer à un comité consultatif

Manufacturer information centre

Presubmission meeting with Health Canada
Presubmission appointment for drugs
Mandatory advance notice from manufacturers
Registration application
INESSS Drug Submission Guidelines
Sign up for electronic submission of a registration application (Checklist 6)
Electronic submission of a registration application (Checklist 6)
Temporary electronic submission of registration applications (other checklists)
Manufacturer Appointments
Post-publication meeting with manufacturers
Notices to Manufacturers
List update schedule in 2025
Fees

Frequently Asked Questions About Prescription Medications

Hepatitis C
Subsequent entry biologics
Médicaments d'exception - oncologie
Generic drugs
Natural health products
Virus de l'immunodéficience humaine

INESSS Drug Submission Guidelines

Guide and additional information for completing the application

INESSS Drug Submission Guidelines (update june 2024)
INESSS Drug Submission Guidelines (with changes - update june 2024)

Subscribe to our newsletter now

SUBMIT A PROJECT REQUEST
ADMINISTRATIVE DOCUMENTS
GET INVOLVED

MISSION-VISION-VALUES
ONGOING PROJECTS
PUBLICATIONS
EMPLOIS

Application INESSS Guides

Android iOS

Access to information Accessibility Déclaration de services aux citoyens Sustainable Development Droits d'auteur Politiques de confidentialité Website development Application mobile

© Government of Québec, 2025